Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Obstructive | 2 | 2013 | 16 | 0.710 |
Why?
|
| Pulmonary Atelectasis | 2 | 2012 | 5 | 0.650 |
Why?
|
| Lung Neoplasms | 3 | 2010 | 356 | 0.620 |
Why?
|
| Pneumonectomy | 2 | 2006 | 10 | 0.500 |
Why?
|
| Spirometry | 1 | 2013 | 10 | 0.430 |
Why?
|
| Bronchodilator Agents | 1 | 2013 | 15 | 0.420 |
Why?
|
| Bronchoscopy | 2 | 2010 | 34 | 0.400 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2012 | 13 | 0.380 |
Why?
|
| Deoxyribonuclease I | 1 | 2012 | 10 | 0.380 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 41 | 0.370 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 91 | 0.320 |
Why?
|
| Bronchial Neoplasms | 1 | 2008 | 4 | 0.290 |
Why?
|
| Adrenergic Agents | 1 | 2007 | 3 | 0.290 |
Why?
|
| Vital Capacity | 1 | 2007 | 7 | 0.280 |
Why?
|
| Forced Expiratory Volume | 1 | 2007 | 17 | 0.280 |
Why?
|
| Shock, Septic | 1 | 2007 | 38 | 0.280 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 75 | 0.270 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 134 | 0.270 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2006 | 5 | 0.260 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 32 | 0.260 |
Why?
|
| Middle Aged | 8 | 2013 | 7138 | 0.230 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 181 | 0.220 |
Why?
|
| Hydrothorax | 1 | 2003 | 3 | 0.210 |
Why?
|
| Hypertension, Portal | 1 | 2003 | 5 | 0.210 |
Why?
|
| Smoking | 1 | 2007 | 473 | 0.210 |
Why?
|
| Aged | 6 | 2013 | 5400 | 0.200 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 72 | 0.200 |
Why?
|
| Humans | 14 | 2021 | 28097 | 0.180 |
Why?
|
| Intermittent Positive-Pressure Breathing | 1 | 2000 | 1 | 0.170 |
Why?
|
| Barium Sulfate | 1 | 2000 | 3 | 0.170 |
Why?
|
| Pneumonia, Aspiration | 1 | 2000 | 4 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2000 | 14 | 0.170 |
Why?
|
| Contrast Media | 1 | 2000 | 96 | 0.160 |
Why?
|
| Male | 7 | 2013 | 13491 | 0.160 |
Why?
|
| Pandemics | 1 | 2021 | 186 | 0.160 |
Why?
|
| Female | 6 | 2013 | 15156 | 0.140 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 371 | 0.130 |
Why?
|
| Equipment Design | 2 | 2021 | 217 | 0.120 |
Why?
|
| Oxygen | 2 | 2012 | 233 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2012 | 12 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 2021 | 0.100 |
Why?
|
| Sodium Chloride | 1 | 2012 | 65 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 202 | 0.090 |
Why?
|
| Critical Illness | 1 | 2012 | 66 | 0.090 |
Why?
|
| Pleural Effusion | 2 | 2002 | 14 | 0.090 |
Why?
|
| Double-Blind Method | 1 | 2012 | 417 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 413 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2006 | 474 | 0.090 |
Why?
|
| Bronchoscopes | 1 | 2010 | 2 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2012 | 1248 | 0.080 |
Why?
|
| Biopsy | 1 | 2010 | 206 | 0.080 |
Why?
|
| Tidal Volume | 1 | 2009 | 6 | 0.080 |
Why?
|
| Adult | 2 | 2012 | 7740 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2010 | 433 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2012 | 2379 | 0.070 |
Why?
|
| Lymphoma, B-Cell | 1 | 2008 | 18 | 0.070 |
Why?
|
| Respiratory Function Tests | 1 | 2007 | 27 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2007 | 210 | 0.070 |
Why?
|
| Prognosis | 2 | 2009 | 803 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 385 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 769 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 521 | 0.060 |
Why?
|
| Exercise Test | 1 | 2005 | 248 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 474 | 0.050 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 2003 | 1 | 0.050 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2003 | 3 | 0.050 |
Why?
|
| Thoracoscopy | 1 | 2003 | 7 | 0.050 |
Why?
|
| Paracentesis | 1 | 2003 | 5 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 56 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 71 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2007 | 2546 | 0.050 |
Why?
|
| Adolescent | 1 | 2010 | 3122 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2003 | 56 | 0.050 |
Why?
|
| Personal Protective Equipment | 1 | 2021 | 14 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 193 | 0.040 |
Why?
|
| Acute Disease | 1 | 2000 | 155 | 0.040 |
Why?
|
| Heart Failure | 1 | 2002 | 249 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2000 | 189 | 0.040 |
Why?
|
| Serum Albumin | 1 | 1999 | 35 | 0.040 |
Why?
|
| United States | 1 | 2021 | 2146 | 0.030 |
Why?
|
| Positive-Pressure Respiration | 1 | 2009 | 14 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 2009 | 44 | 0.020 |
Why?
|
| Steroids | 1 | 2009 | 54 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2009 | 152 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 214 | 0.020 |
Why?
|
| Models, Biological | 1 | 2009 | 466 | 0.020 |
Why?
|
| Lung | 1 | 2009 | 379 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2002 | 11 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 1999 | 10 | 0.010 |
Why?
|
| Plasma | 1 | 1999 | 32 | 0.010 |
Why?
|